Pipeline of Asthma Market Covering 129 Companies Reviewed for H1 2016 in New Research Report – PR Newswire (press release)

Pipeline of Asthma Market Covering 129 Companies Reviewed for H1 2016 in New Research Report
PR Newswire (press release)
RnRMarketResearch.com adds "Asthma – Pipeline Review, H1 2016" market research report with comparative analysis of Asthma therapy at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) …

and more »

View full post on asthma – Google News

Leading companies and potential for market growth – Virtual Press Office (press release)

Leading companies and potential for market growth
Virtual Press Office (press release)
Overall world revenue for asthma and COPD therapies will reach $33.1bn in 2014, our work forecasts. We predict slow revenue growth from 2014 to 2018 and faster growth from 2018 to 2024. Rising demand for asthma and COPD drugs, expanding …
Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for Satellite PR News (press release)

all 6 news articles »

View full post on asthma – Google News

Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA … – Economic Times

Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA
Economic Times
NEW DELHI: Indian drug makers, including Aurobindo and Glenmark, are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. Last week the US Food and Drug

View full post on asthma – Google News